ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Surgery

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,546Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 176

$753K Total Retail Price of All Prescriptions

Rank: 1 out of 176

288 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

53% of this provider’s 288 patients filled at least one prescription for a schedule three drug, compared to an average of 45%.

Risky Drugs to Seniors

5% of this provider’s 3,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
ACETAMINOPHEN-CODEINE 735 161 S3 10 1 12
DESOXIMETASONE 594 117 10 2 22
NIZATIDINE 542 176 10 3 25
FLUNISOLIDE 466 107 10 4 37
ADVAIR DISKUS 455 100 5 38
PROMETHAZINE HCL 436 80 R 6 27
VENTOLIN HFA 399 102 7 44
TRIAMTERENE-HCTZ 344 102 8 21
MECLOFENAMATE SODIUM 314 75 10 9 52
CHLORHEXIDINE GLUCONATE 308 67 10 54
ENALAPRIL MALEATE 302 83 11 19
AMOXICILLIN 302 65 11 47
CLONIDINE HCL 285 69 13 33
CYCLOBENZAPRINE HCL 285 55 R 13 30
SIMVASTATIN 276 75 15 3
PROAIR HFA 267 45 16 31
AMPICILLIN TRIHYDRATE 257 73 10 17 62
IBUPROFEN 252 70 18 29
HYDROXYZINE HCL 232 16 R 19 68
TRIAMCINOLONE ACETONIDE 214 50 20 58
HYDROCODONE-ACETAMINOPHEN 197 47 S3 21 1
PENICILLIN V POTASSIUM 187 44 22 76
NAPROXEN 183 65 23 65
METFORMIN HCL 170 48 24 7
AZITHROMYCIN 162 33 25 32
FUROSEMIDE 161 40 26 5
KLOR-CON 10 145 28 27 66
SURE COMFORT ALCOHOL 132 30 28 89
HYDROCHLOROTHIAZIDE 132 58 28 13
POTASSIUM CHLORIDE 131 50 30 11
GLIPIZIDE 129 32 31 41
KETOCONAZOLE 115 13 32 94
FAMOTIDINE 108 31 33 25
CLOTRIMAZOLE 108 21 33 98
SYMBICORT 107 23 35 99
NIFEDIPINE ER 106 32 36 78
FELODIPINE ER 92 28 37 105
GABAPENTIN 88 39 38 23
AMLODIPINE BESYLATE 88 33 38 9
TAMSULOSIN HCL 86 39 40 24
PREDNISONE 84 0 41 36
FLOVENT HFA 78 31 42 110
TRAMADOL HCL 78 38 42 16
SPIRIVA 73 38 44 92
SINGULAIR 73 26 44 118
ZOLPIDEM TARTRATE 71 16 46 64
LISINOPRIL 67 39 47 4
METOPROLOL TARTRATE 58 22 48 8
LACTULOSE 55 21 49 136
PHENYTOIN SODIUM EXTENDED 55 0 49 136
SPIRONOLACTONE 54 0 51 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.